|
Articles |
| 1113 |
Appropriate Use of Antibiotics for
URIs in Children: Part I. Otitis Media and Acute Sinusitis
SCOTT F. DOWELL, M.D., M.P.H., BENJAMIN SCHWARTZ, M.D., WILLIAM
R. PHILLIPS, M.D., M.P.H., and THE PEDIATRIC URI CONSENSUS TEAM
The first part of this two-part article reviews the principles of antibiotic
use in the treatment of otitis media and acute sinusitis in children, and ways
in which antibiotic use could be curtailed without compromising patient
care. |
 |
Patient information:
"Otitis Media with Effusion," p. 1123 |
| 1126 |
Postexercise Systolic Blood Pressure
Response: Clinical Application to the Assessment of Ischemic Heart
Disease
ALLEN J. TAYLOR, M.D., and GEORGE A. BELLER, M.D.
A
three-minute systolic blood pressure ratio of greater than 0.90 has a
diagnostic accuracy of about 75 percent for the detection of coronary artery
disease. Higher values for this ratio are associated with more extensive
coronary artery disease and an adverse prognosis after myocardial
infarction. |
| 1133 |
Herbal 'Health' Products: What Family
Physicians Need to Know
THERESE ZINK, M.D., M.P.H., and JODI CHAFFIN, R.PH.
Family physicians can benefit from knowing about some of the popular herbal
preparations their patients are taking and from becoming familiar with what is
currently known about their effectiveness, dosages, side effects, toxicities
and drug interactions. |
| 1145 |
Evaluating Proteinuria in
Children
MAHMOUD LOGHMAN-ADHAM, M.D.
Proteinuria is a common laboratory finding in children. It can be identified as
either a transient or persistent finding and can represent benign conditions or
serious disease. |
 |
Patient information:
"Proteinuria in Children," p. 1158 |
| 1163 |
Breast Cancer in Older
Women
LODOVICO BALDUCCI, M.D., and D. MELESSA PHILLIPS, M.D.
Screening mammography is recommended in women up to 85 years of age who have a
life expectancy of three years. Several options for the management of localized
and metastatic breast cancer are available to older women. |
1175 |
Clinical Pharmacology
New Drugs for Alzheimer's Disease
VINCENT W. DELAGARZA, M.D.
Two cholinesterase-inhibiting medications are now available to delay the
progression of Alzheimer's disease, and many other agents are presently being
studied in the search for ways to minimize the ravages of this all-too-common
disorder. |